p53 activity is selectively licensed in the Drosophila stem cell compartment

Open accessCopyright infoDownload PDFeLife Lens

p53 activity is selectively licensed in the Drosophila stem cell compartment

Affiliation details

DOI: http://dx.doi.org/10.7554/eLife.01530Published March 11, 2014 Cite as eLife 2014;3:e01530


Oncogenic stress provokes tumor suppression by p53 but the extent to which this regulatory axis is conserved remains unknown. Using a biosensor to visualize p53 action, we find that Drosophila p53 is selectively active in gonadal stem cells after exposure to stressors that destabilize the genome. Similar p53 activity occurred in hyperplastic growths that were triggered either by the RasV12 oncoprotein or by failed differentiation programs. In a model of transient sterility, p53 was required for the recovery of fertility after stress, and entry into the cell cycle was delayed in p53- stem cells. Together, these observations establish that the stem cell compartment of the Drosophila germline is selectively licensed for stress-induced activation of the p53 regulatory network. Furthermore, the findings uncover ancestral links between p53 and aberrant proliferation that are independent of DNA breaks and predate evolution of the ARF/Mdm2 axis.

DOI: http://dx.doi.org/10.7554/eLife.01530.001

eLife digest

The most common genetic change seen in cancer patients produces a faulty version of the p53 protein, which normally restricts tissue growth. This change promotes cancer because cells can now divide faster and fail to die when they should. Much remains to be learned about how p53 functions to restrain growth. As p53 is found in primitive organisms, and cancer is unlikely to have significantly influenced evolution, suppressing tumor formation was almost certainly not the original function of this gene. Furthermore, p53 works in a different way compared to many other tumour suppressors. Therefore, prevention of cancer is likely to have evolved as a side effect derived from more ancient functions.

Recently, a link between p53 and stem cells has been uncovered. Stem cells are special because they can develop into many different types of cells, and they are crucial for the growth and repair of tissues. To form a particular type of cell, the stem cell divides to create two daughter cells. Commonly, one daughter cell stays in the stem state, whereas the other becomes a particular type of cell, such as a nerve cell or muscle cell. Because of this special property, scientists hypothesize that stem cells have special mechanisms to protect them from DNA damage that might partially depend on p53. This would prevent the spread of damaged genomes that would otherwise occur among daughter cells.

To learn more about how p53 influences stem cells, Wylie, Lu et al. monitored its activity in the gonads of fruit flies, which are a powerful genetic model. They found that damaging DNA activates p53 in stem cells and their daughter cells, but not in other types of cells that have been damaged. In addition, p53 is activated by the uncontrolled growth and division of stem cells in the gonad, even when DNA is not damaged. This is unexpected since molecules linking inappropriate growth to p53 were thought to be present only in mammals. Therefore, it appears that the tumor-suppressing behavior of p53 in mammals was adapted from its more ancient ability to regulate stem cell growth—an ability that evolved before organisms divided into vertebrates and invertebrates.

DOI: http://dx.doi.org/10.7554/eLife.01530.002

Main text


Throughout the animal kingdom, p53 occupies a central position within conserved stress response networks. The protein integrates diverse signals associated with DNA damage and uncontrolled proliferation to govern adaptive downstream responses such as increased DNA repair, arrested cell cycle, and apoptosis (Vousden and Lane, 2007). Where examined, the genes encoding p53 are not essential for viability but have been implicated as regulators of aging (Derry et al., 2007; Donehower et al., 1992; Lee et al., 2003; Sogame et al., 2003). It is now well appreciated that ancestral roles for this gene family must have predated functions in tumor suppression. In support of this, members of the p53 gene family are present in unicellular protists and short-lived multicellular organisms (Lu et al., 2009; Mendoza et al., 2003; Nordstrom and Abrams, 2000). Furthermore, cancer was probably a negligible source of selection pressure during the course of human evolution (Aranda-Anzaldo and Dent, 2007) and the combined removal of canonical p53 effectors (p21, Puma, and Noxa) does not account for tumor suppression in mice (Valente et al., 2013). These and other observations suggest that tumor suppressive roles for the p53 family were co-opted from primordial functions, some of which may have been linked to meiotic recombination (Lu et al., 2010).

In recent years, considerable evidence has surfaced linking p53 action to stem cell biology. For example, in mammary stem cells p53 promotes asymmetric division and cell polarity, thereby helping to limit the population of stem cells in the mammary gland (Cicalese et al., 2009). Furthermore, reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is greatly increased in p53 deficient cells, suggesting that p53 may act as a ‘barrier for induced pluripotency’ (Krizhanovsky and Lowe, 2009). Consistent with this, several labs have shown that p53 induces embryonic stem cell differentiation to maintain genomic stability after DNA damage (Lin et al., 2005; Neveu et al., 2010; Zhao and Xu, 2010). Together with recent studies in planaria, these observations indicate that an ancestral focus of p53 action could operate in stem cells (Pearson and Sanchez Alvarado, 2009). We directly tested this possibility using a p53 biosensor to visualize Drosophila germline stem cells and their progeny. When DNA breaks were exogenously imposed or intrinsically engineered, Drosophila p53 (Dp53) was activated selectively in germline stem cells (GSCs) and their immediate daughters, indicating that these cells are uniquely licensed for p53 action. Furthermore, in various germline tumor models Dp53 was constitutively hyperactivated, suggesting that ancient links between p53 and inappropriate growth predate canonical effectors that connect these regulatory networks (e.g., ARF and MDM2).


Damage-induced Dp53 activity in the germline is restricted to stem cells

The Drosophila gonad is a classic system for studying the stem cell compartment since stem cells, their immediate daughters, and the surrounding niche are easily identified. In the ovary, germline stem cells (GSCs) undergo self-renewing divisions that typically produce a GSC and a cystoblast (CB). These GSCs support egg production throughout the lifespan of female adults (Figure 1B). We used in vivo biosensors (Lu et al., 2010; Brodsky et al., 2000) to visualize p53 activity as GSCs responded to various sources of stress (Figure 1A). To exclude technical artifacts, two GFP reporters were used—one localizes to the nucleus (p53R-GFPnls) and the other does not (p53R-GFPcyt). As previously described (Lu et al., 2010), programed p53 activity triggered by meiosis was only observed in region 2 (Figure 1B). After exposure to ionizing radiation (IR) stress, p53 activity was induced in virtually all germaria. However, despite widespread damage to the organ (Figure 1—figure supplement 1), this unprogrammed response was remarkably restricted to germline stem cells (GSCs) and their immediate progeny (CBs) (Figure 1C,E). Furthermore, as seen in Figure 1—source data 1A, this response was highly penetrant. Since we rarely observe reporter activation only in CBs, the signal seen in CBs probably reflects GFP perduring from the parental stem cells. Furthermore, post-irradiation levels of GFP were noticeably more robust than the programed activity during meiosis (compare solid arrows to open arrows in Figure 1C,D) (Lu et al., 2010). As expected, p53 biosensor activity was not observed within the ovary of p53−/− animals and was also absent from ovaries lacking the upstream Chk2 kinase (Figure 1E, Figure 1—figure supplement 2A′,A′′, Figure 1—source data 1A).

Double stranded DNA breaks (DSBs) are responsible for many of the biological effects associated with IR (Ward, 1994). Therefore, to determine whether DSBs are sufficient to induce the p53 reporter, we ubiquitously expressed the I-SceI endonuclease in the germline of flies engineered to harbor a single I-SceI recognition site in each nucleus. As seen with IR exposure, p53 activity occurred only in GSCs/CBs when DSBs were induced (Figure 1D,E, Figure 1—figure supplement 2B, Figure 1—source data 1B). Furthermore, it is notable that a single DSB was sufficient to provoke robust p53 activity in GSCs/CBs. Therefore, whether exogenously imposed or intrinsically engineered, DSBs triggered p53 selective activation that was confined to GSCs and their immediate progeny. Furthermore, this stem cell restricted response is clearly under genetic control. For example, in directed tests of chosen mutants we identified a class of lesions that exhibit non-selective p53 action throughout the ovary only after IR challenge (see Figure 1—figure supplement 3, Figure 1—source data 1C). Therefore, p53 is present and potentially functional in all cells of the ovary but, under normal conditions, its action is somehow confined to GSCs and their immediate progeny.

To ask whether this pattern might reflect a general property of germline stem cells, we similarly examined the male gonad. As seen in the ovary, we observed selective p53 reporter activation in GSCs and their immediate progeny (gonioblasts) in irradiated testis (Figure 2). Likewise, stimulus-dependent activity required p53 and was not seen in unchallenged testis (Figure 2C, Figure 2—figure supplement 1A,B, Figure 1—source data 1A). Occasionally, the biosensor was also present in early spermatogonial cysts, perhaps reflecting perduring GFP and/or independent activation associated with dying cells (Figure 2D–D′′, Figure 2—figure supplement 1D-E′′). Collectively, the observations in Figure 1 and Figure 2 demonstrate that selective p53 activation in the stem cell compartment is a general property of germline tissues exposed to genotoxic stress. We note that perturbation-dependent induction of the p53 biosensor in gonadal stem cells was highly penetrant (Figure 1E, Figure 2C). However, like all stress responses, the strength of signal and the number of responding cells were variable from animal to animal (Figure 1C,D, Figure 2D) perhaps reflecting distinct cell cycle dynamics occurring in GSCs at the time of challenge.

Genome instability provokes p53 action in the stem cells

We tested whether other genome destabilizing factors elicited similar p53 activity in stem cells. To examine the effect of deregulated retrotransposons, we introduced the p53 biosensor into cutoff or aubergine mutant animals. These genes encode essential components of the piwi-associated RNA (piRNA) pathway, acting to silence retrotransposons in the germline (Chen et al., 2007). The corresponding mutants exhibit disregulated retrotransposition, reduced fecundity, and egg shell ventralization (Chen et al., 2007). Figure 3A shows that in cutoff mutants induction of p53R-GFP occurs exclusively in GSCs and their progeny at a penetrance comparable to irradiated wild-type animals (Figure 3—source data 1). Frequent p53 activation in the germline was similarly observed in the GSCs of aubergine mutants (Figure 3B) and rad54 mutants defective for DNA repair (Figure 3C). However, in contrast to cutoff mutants, the p53 biosensor was not entirely restricted to GSCs/CBs in these mutants (Figure 3—figure supplement 1B,C, Figure 3—source data 1) perhaps reflecting differences in the kinetics of repair that may occur in these different backgrounds (Klattenhoff et al., 2007).

p53 enables recovery from stress-induced sterility and proper exit from proliferative arrest

In somatic cells, Dp53 promotes stress-induced apoptosis (Sogame et al., 2003). Therefore, we examined the germarium for evidence of cell death by detecting cleaved caspase-3. In the 24-hr period post challenge, over 90% of GSCs induce the reporter but the average incidence of apoptosis was less than 4% (Figure 4—figure supplement 1, Figure 4—source data 1A). Furthermore, we did not observe an obvious role for p53 in regulating stem cell numbers in the Drosophila ovary in the presence or absence of stress (Figure 1—source data 1, Figure 4—source data 1A). We also used α-pH2Av immunostaining, the Drosophila counterpart of mammalian pH2AX (Mehrotra and McKim, 2006), to follow the repair of DSBs after IR and found that resolution of these lesions was unaffected in the germaria of p53 mutants (Figure 4—figure supplement 2). Similarly, in BrdU incorporation studies, the rates at which wild-type and p53−/− GSCs/CBs entered proliferative arrest were also indistinguishable (Figure 4A). However, in the post-stress period, we did observe that p53 mutants were significantly delayed for re-entry into the cell cycle (Figure 4A). Furthermore, this defect is reversed in p53 genomic rescue strains confirming an assignment of this phenotype to the p53 locus (Figure 4—source data 1B).

To examine how the action of p53 might coordinate adaptive stress responses in GSCs, we developed a fertility recovery assay. In this study, females were irradiated to induce transient sterility and the recovery of fertility was scored over time (see ‘Materials and methods’). Figure 4B shows that wild-type females recovered from infertility within 1 week post-exposure to IR at a dose of 11.5 krad. In contrast, females lacking p53 remained permanently infertile even when tracked over 2 weeks after IR (Figure 4B). To confirm that p53 gene function is responsible for this phenotype, we tested p53 females carrying a genomic rescue fragment spanning the p53 gene (see ‘Materials and methods’). We tested two rescue strains and in both cases the sterility defect was reversed (Figure 4B). However, neither rescue strain fully restored fertility to wild type levels, possibly reflecting incomplete restoration of wild type regulation in the transgenes.

To test whether we could link the fertility defect (Figure 4B) to the cell cycle defects observed at a lower dose (Figure 4A), we examined fertility and cell cycle kinetics at an intermediate dose (9 krad) of IR. After this challenge, p53−/− females exhibit impaired fertility, whereas WT flies remained fertile (Figure 4—figure supplement 3). We performed BrdU incorporation studies over 7 days with females irradiated at 9 krad and assayed the number of germaria that had BrdU positive cells in region 1. Under these conditions, we observed persistently reduced proliferative activity in p53−/− stem cells even 7 days after IR (Figure 4—figure supplement 3C, Figure 4—source data 1C). This result is consistent with the possibility that fertility defects seen in p53−/− flies are linked to the impaired cell cycle kinetics found in GSCs. Furthermore, the data in Figure 4B and Figure 4—figure supplement 3A suggest that radiosensitivity associated with the p53−/− genotype, previously been documented for larval stages (Sogame et al., 2003), also applies to germline tissue.

Uncontrolled stem cell proliferation activates p53

Oncogenic properties are thought to simulate ‘stemness’ and oncogenic signals frequently result in p53 activation (Vousden and Lane, 2007). However, it is not known whether this regulatory axis is conserved beyond mammals. To test whether inappropriate growth triggers Drosophila p53 function, we examined the p53 biosensors in various germline tumor models. First, we expressed an oncogenic form of RAS commonly found in human cancers together with the p53 biosensor (Lee et al., 1996). Transient expression of the Drosophila RasV12 counterpart provoked robust p53 activation mainly in the GSCs and CBs (Figure 5B, Figure 5—source data 1). Figure 5E shows that another oncoprotein, Cyclin E, produced similar results. We also examined these biosensors in bam mutants, where a block in differentiation causes extensive hyperplasia (McKearin and Ohlstein, 1995) and in these tumors extensive reporter activity was also seen (Figure 5C,D). Likewise, expanded BMP (bone morphogenic protein) signaling (Chen and McKearin, 2003) or reduced Lsd1 (lysine-specific demethylase 1) activity (Eliazer et al., 2011) in neighboring somatic cells can also cause inappropriate growth and robust p53 activity was similarly observed in these germline tumors as well (Figure 5F,G,H). Therefore, whether caused by forced oncoprotein expression (panels B, E), failed differentiation programs (panels C, D), or expansion of the stem cell niche (panels F–H), inappropriate growth of Drosophila tissues was consistently accompanied by p53 activity. As seen with genotoxic stress, biosensor responses seen in these contexts was somewhat variable, perhaps reflecting complex signaling and/or cell cycle dynamics that occur in these tumor models. Technical sources of variation linked the UAS-GAL4 driver system and/or non-uniform accumulation of the oncogenic product could also contribute to variability in these contexts.

We considered the possibility that inappropriate growth might indirectly activate p53 by provoking DNA damage. To test this, we stained bamΔ86 ovaries for pH2Av (Joyce et al., 2011). We observed very few pH2Av foci in bam tumors and, notably, these foci did not co-localize with p53 biosensor activity (Figure 5—figure supplement 1). Therefore, p53 activity in these tumors is not triggered by DSBs but instead, appears to be directly triggered by signals associated with hyperplastic growth.

As seen in Figure 5, diverse types of hyperplastic growth triggered constitutive p53 activity. To ask how p53 functions in these tumors, we examined bam−/− ovaries that were either WT or null for p53. Tumor size was not significantly altered in the absence of p53, but we did observe dramatically altered cytology in tumors that lacked p53. As seen in Figure 6A, bam−/− ovarian cysts are typically filled with stem-like cells that exhibit round or dumbbell-shaped fusomes when stained with α-HTS (Lin et al., 1994). As documented in Figure 6C, defective fusomes were seen in all bam−/−;p53−/− cysts and, in nearly half of these unusually large nuclei were observed. Though not quantified, micronuclei were also prevalent in these samples. Since defective fusome morphologies and irregular nuclei are consistent with aberrant mitosis, our data suggests a role for p53 in promoting proper cell cycle progression in these stem-like tumors.

Figure 6.
Download figureOpen in new tabDownload powerpointFigure 6. Abnormal fusomes and irregular nuclei are seen in bam−/−p53−/− tumors.

(A–A’) Cells in bam−/− tumors have rounded fusomes normally associated with the undifferentiated GSC fate. These are detected by α-HTS staining (red in B, white in B’). The nuclei of these cells counterstained with DAPI have diameters less than 10 μm (blue in B). (BB’) bam−/−;p53−/− tumors frequently exhibit disorganized fusomes detected here by α-HTS staining (red in C, white in C’, yellow arrowhead). These tumors also have many fragmented and enlarged nuclei with a diameter significantly greater than 10 μm (blue in C, yellow arrow). (C) Quantification of altered fusome structure and irregular nuclei in bam−/− and bam−/−;p53−/− tumors. Note that in panel C, counts for irregular nuclei do not include micronuclei. A total of 14 cysts were assayed in bam−/−;p53−/− and 8 cysts were assayed for bam−/−. All scale bars, 10 μm.

DOI: http://dx.doi.org/10.7554/eLife.01530.021

To further examine the functional role of p53 in this context, we examined gene expression profiles of bam−/− ovaries that were WT or null for p53 by microarray. In total, we found that 297 gene transcripts were altered by at least twofold or greater in the absence of p53. Table 1 lists the top 20 genes that are affected (upregulated or downregulated) by p53 in these tumors. Using the Gene Expression Commons (GEXC) tool, we compared these gene sets to existing germline, embryonic, and somatic expression profiles. We did not find a coherent pattern among the top 20 genes that are normally upregulated by p53. However, among the top 20 genes that are normally suppressed by p53 in these germline tumors, we observed a modest enrichment for transcripts that were absent in either the embryonic stages or other somatic tissues (Table 1—source data 1). These data, together with our histological studies (Figure 6), establish that p53 exerts functional activities that impact cellular and molecular properties of Drosophila stem cell tumors.

View this table:
Table 1.

p53 status impacts expression profiles in bam−/− tumors

DOI: http://dx.doi.org/10.7554/eLife.01530.022

Table 1—source data 1. Expression features of the top 20 genes suppressed by p53.

The top 20 genes that were suppressed by p53 in bam−/−;p53−/− tumors (see Table 1) were examined using GEXC (Seita et al., 2012) to identify enriched pathways. Using this collection we observed a mild enrichment for genes that were absent in embryos or absent in adult somatic tissues relative to all genes in the fly genome.

DOI: http://dx.doi.org/10.7554/eLife.01530.023

Download source data [table-1—source-data-1.media-5.xlsx]


We found that adult Drosophila exposed to genotoxic stress or genome destabilizers selectively activated p53 in GSCs and their immediate progeny. This striking specificity was observed despite widespread Dp53 expression (FBgn0039044 m.; Jin et al., 2000; Ollmann et al., 2000) and widespread tissue damage (Figure 1—figure supplement 1). We note that stem cell specificity was not an artifact intrinsic to the biosensors, since independent reporters behaved similarly in both the female and male germline and required the wild-type Dp53 locus in both cases. Furthermore, in certain mutant backgrounds stress-induced activity restricted to GSCs was lost and non-selective p53 activation was widespread throughout the ovary (Figure 1—figure supplement 3B′). Therefore, despite the fact that it is present and activatable throughout the gonad, functional p53 is restricted to stem cells and their immediate progeny by specific genetic determinants.

Collectively, our work supports previous indications that there is an intimate and ancient link between p53 and stem cell biology (Pearson and Sanchez Alvarado, 2009). Our findings also offer rare and novel opportunities to operationally mark the stem cells in the fly germline, as visualized by p53R-GFP. This marker is distinct from conventional stem cell labels (Deng and Lin, 1997) since it is not constitutively expressed but, instead, represents a functional output that is conditional upon a perturbation. We further note that like all reporter systems, our p53 biosensors may not reflect the full scope of effector output regulated by this network, and activities visualized here could transmit only subsets of p53-mediated responses. Nevertheless, despite this possible limitation, our results are consistent with suggestions that stem cells may be acutely sensitive to sources of genomic instability with a higher propensity for engaging adaptive responses relative to other cells (Mandal et al., 2011; Sperka et al., 2012). We propose that in reproductive tissues, the p53 regulatory network is either preferentially licensed in stem cells or selectively blocked outside of this compartment.

What upstream regulators might specify p53 activation in GSCs/CBs? Given that stem cells have unique properties, p53 activation in these cells might lie downstream of a novel pathway. Consistent with this idea, ATR expression, was not rate limiting for p53 activation in the germline (Figure 1—figure supplement 3A′, Figure 1—source data 1C). Furthermore, unlike meiotic induction, p53 induction in GSCs/CBs was independent of the topoisomerase, Spo11 (Figure 1—source data 1A; Lu et al, 2010). Chk2 could contribute to the selective activation in stem cells seen here, but since Chk2 is also broadly expressed and functionally associated with oocyte development throughout the ovary (Abdu et al., 2002; Oishi et al., 1998) any potential role in GSCs must extend beyond a simple presence or absence of this kinase.

Our findings also imply stimulus-dependent effectors of p53 in stem cells that are not yet appreciated. For example, within detection limits, we observed no obvious connection between p53 status and apoptosis, DNA double-strand break repair, or cell cycle arrest. However, irradiated p53−/− GSCs were significantly delayed in the re-entry phase for cell cycle. Future studies will explore this defect and also examine progeny derived from stressed GSCs for transgenerational phenotypes that might be adaptive.

Our discovery that p53 action is coupled to hyperplasia in a non-vertebrate species was unexpected for two reasons. First, the role of this gene family as a tumor suppressor is thought to be a derived feature that evolved only in vertebrate lineages. Second, the canonical ARF/MDM2 pathway that links aberrant growth to p53 is absent outside of higher vertebrates (Lu et al., 2009). Surprisingly, our combined results suggest that ancient pathways linking p53 to aberrant stem cell proliferation may predate the divergence between vertebrates and invertebrates.

Materials and methods

Fly stocks and genetics

All fly stocks were maintained at 22–25°C on standard food media. We obtained rad54, aubergine and cutoff mutants: rad54RU, rad54AA, aubHN, aubQC, cuffWM, and cuffQQ from T Schupbach (Princeton University, Princeton, NJ, USA); c587-GAL4, UAS-dpp, UAS- Lsd1KD (Eliazer et al., 2011), homozygous viable allele of bamΔ86 (McKearin and Spradling, 1990; McKearin and Ohlstein, 1995), nanos-GAL4VP16, and UASp-tkvCA (Chen and McKearin, 2003) have been described previously. All other stocks were obtained from Bloomington Stock Center (Indiana University, Bloomington, IN, USA). The Dp53 rescue strain was engineered by ϕC31 integration of a 20-kb genomic fragment BAC containing the Dp53 locus into an attP site on the X chromosome of the PBac{y + -attP-9A}VK00006 line (Bloomington #9726). The parent BAC CH322-15D03 was obtained from the P[acman] resource library (Venken et al., 2009) and Rainbow Transgenic Flies performed the injection and screening for recombinants. The I-SceI endonuclease strain was generated by K Galindo (Galindo et al., 2009), which was crossed to p53R-GFPnls(STI150); HS-(70Flp)(70 I- Sce I)/TM6 for heat-inducible I-SceI endonuclease expression. Adult females were fattened for 2–3 days after eclosion and then subjected to heat shock in a circulating water bath at 37°C for 90 min and repeated for three consecutive days. 24 hr after the last heat shock, ovaries were dissected for immunostaining. For forced proliferation assays, two GAL4 lines were used: nanos-GAL4VP16 was used to achieve overexpression in the germline with UAS constructs for RasV12, CyclinE, and Thickveins (Rorth, 1998). c587-GAL4 was used to achieve overexpression of UAS constructs of Dpp or Lsd1-RNAi in the somatic cells of the ovariole tip (Song et al., 2004). For cyclinE overexpression, stocks were maintained at 25°C and female virgins were collected upon eclosion, shifted to 29°C for 4–5 days then subjected to immunostaining. For the RasV12 studies, female virgins were shifted to 29°C for 1 day and then shifted down to 25°C for 3 days prior to immunostaining. The Gal4-UAS system (adapted from yeast) often produces optimal expression at temperatures higher than 25°C. Since the UAS-Rasv12 and UAS-CyclinE constructs were not optimized for expression in the germline we applied these temperature shifts to produce more penetrant phenotypes.

Irradiation assay

Well-fed flies were exposed to ionizing radiation using a Cs-137 Mark 1-68A irradiator (JL Shepherd & Associates, San Ferando, CA, USA) at a dose of 4 krad unless otherwise noted. When irradiating several genotypes, each genotype was placed in an individual vial, and all vials were exposed to IR at the same time on a rotating turntable inside the irradiator. For visualizing reporter activation after IR, flies were dissected 24 hr post-IR to allow for stable GFP expression.

Immunostaining of fly tissue

3- to 5-days-old well-fed females were dissected in PBS and fixed in 4% EM-grade formaldehyde (Polysciences, Warrington, PA) diluted in PBS-0.1% tween-20, with three times the volume of heptane. After washing, tissues were blocked in 1.5% BSA, then incubated with primary antibodies at 4°C overnight. Antibodies used: rabbit α-GFP (Invitrogen, Carlsbad, CA); rabbit α-pH2Av (kindly provided by K McKim with specific staining protocols), rabbit α-cleaved caspase 3 (Asp175) (Cell Signaling, Danvers, MA); mouse α-Armadillo, mouse α-BrdU (Sigma, St. Louis, MO), mouse α-HTS clone 1B1 (Developmental Studies Hybridoma Bank, Iowa City, IA), and rat α-Vasa (Developmental Studies Hybridoma Bank). For fluorescence visualization, Alexa-488, 568 (Invitrogen), and DyLight 649 (Jackson ImmunoResearch, West Grove, PA) secondary antibodies were used and 0.1 μg/ml of DAPI (Invitrogen) for DNA staining was added in the first wash step. After three washes, ovaries were further hand dissected and mounted in VECTASHIELD (Vector Laboratories, Burlingame, CA) for microscopy imaging. For validating stimulus-dependent p53 action as visualized by the reporters, we routinely confirmed absence of GFP expression using flies null for Dp53. We note that p53R-GFPnls shows constitutive expression independent of p53 in a subset of gut cells and in the region of the testis containing elongated spermatids, reflecting position effects upon this transgene.

Fertility tracking and proliferative arrest assay

In fertility assays, two p53 null alleles, 238H (ns) and 5A-1-4 (k1) were used in trans-combination to reduce genetic background influences. Two wild-type strains, yw and w1118 were used for comparison. p53 rescue transgenes were tested in a transheterozygous p53−/− background (A1; ns/k1 and A2; ns/k1) to exclude contributions from background modifiers. 5- to 7-day-old females were irradiated at desired doses (11.5 krad for Figure 4B and 9 krad for Figure 4—figure supplement 3) and fertility was tracked over time in groups. Each group contained 10 females and five unirradiated wild-type Canton-S males. The animals were transferred to a new vial at designated time points, and fertility was scored by the presence of larvae 10 days after the parents were removed. Each trial contained 2 to 15 replicates per genotype. For Figure 4B percentages of fertile samples are plotted based on five trials. In the proliferative arrest assay, ovaries were dissected and immersed in Grace’s media containing BrdU (10 µM) for 1 hr at room temperature. After fixation, ovaries were treated with 2N HCl for 30 min then 100 mM of borax was added for 2 min to neutralize the pH. Tissues were then processed for blocking and regular immunostaining.

Statistical analysis

For all statistical analysis, data were placed into GraphPad Prism software. For statistics on the IR and Isce-I reporter activation (Figure 1G, Figure 1—source data 1), one-way ANOVA test was performed on all genotypes with a Tukey’s Multiple Comparison post-test. Reporter activation in aubergine, cutoff, and rad54 mutants (Figure 3, Figure 3—source data 1) was analyzed using a two-tailed unpaired t-test comparing the transheterozygous mutant to the heterozygous control. The same analysis was carried out for region 3 and stage 2–8 (Figure 3—figure supplement 1, Figure 3—source data 1). For statistical analysis on fertility and BrdU incorporation assays (Figure 4), one-way ANOVA test was performed for each time point with a Dunnett post-test in which p53−/− data was the control. For cleaved-caspase 3 analysis (Figure 4—figure supplement 1), the data was analyzed using a two-tailed unpaired t test. In cases where replicates produce identical values incompatible with the prism two-tailed unpaired t-test tool, one value was negligibly revised to enable computation by this software (e.g., when both values were 0, one value was changed to 1.0e−12).

Microarray and Gene Expression Commons (GEXC) analysis

About 200 ovaries from bam or bamp53 adult females were dissected in batches and pooled together to extract total RNA using Trizol (Invitrogen). After verifying RNA integrity using Bioanalyzer (2100; Agilent), whole-genome expression of each genotype was analyzed using Affymetrix Drosophila Genome 2.0 Array at UTSW Genomics & Microarray core facility. Microarray data sets were uploaded to Gene Expression Commons (https://gexc.stanford.edu) and analyzed with 17 other public available data sets. In Gene Expression Commons, raw microarray data is individually normalized against a large-scale common reference (for Drosophila genome, n = 2687 as of Nov 2013), mapped onto the probeset meta profile. This strategy enables profiling of absolute expression levels of all genes on the microarray, instead of conventional methods where differences in gene expression are compared only between samples within an individual experiment (Seita et al., 2012).



We thank the following for kindly providing materials: Dr Trudi Schupbach for rad54, aubergine and cutoff mutants, Dr Dennis McKearin for bam, nanos-GAL4VP16, and UASp-TkvCA strains, and Dr Kim McKim for α-pH2Av and staining protocols. We thank Dr Susan Eliazer for providing unpublished strains and information. We greatly appreciate Ashley Aguilar for help with dissections and immunohistochemistry and Jessica Alatorre for maintaining fly stocks.

Decision letter

Carol Prives, Reviewing editor, Columbia University, United States

eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see review process). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled “p53 activity is selectively licensed in the Drosophila stem cell compartment” for consideration at eLife. Your article has been evaluated by a Senior editor, a Reviewing editor, and 3 reviewers.

The Reviewing editor and the three reviewers discussed their comments and the Reviewing editor has assembled the following comments that require your response before we can make a determination on the suitability of this work for publication in eLife.

The referees feel that your findings are intriguing and potentially of sufficient interest for the broad audience of eLife because of the provocative finding that p53 may be activated exclusively in germline stem cells after myriad forms of stress. Yet, it was felt that your findings as described are somewhat preliminary and that further details on the roles of p53 in stem cells need to be provided. The reviewers also felt that the text has to be clarified in several instances. Please consider the following points: 

1) The authors observe a phenotype of p53 mutants on recovery from sterility and re-entry into the cell cycle after irradiation. However, it's not clear if the delay in cell cycle re-entry (which is quite modest, especially after 72 hours after irradiation) causes the infertility. For example, at higher doses of irradiation (Figure 4–figure supplement 3), wild type flies did not become sterile and p53 mutants showed a reduced fertility (but not complete infertility). Does this correlate with an accelerated re-entry into the cell cycle (when compared with lower doses of irradiation)? 

2) The role of apoptosis in these phenotypes is also insufficiently explored. Staining with cleaved caspase 3 was performed but did not implicate apoptosis. And is it clear whether inhibition of apoptosis would produce any phenotype in these germaria? Further, what is measured is caspase 3 activation per germarium, which doesn't take into account the number of GSCs or CBs per germarium. C3 is a good marker for induction of apoptosis but doesn't indicate how many cells may have already died and been cleared. 

3) What is the role of p53 in stem cell tumors? The authors show activation of p53 in different tumor models. But what is the phenotype of these tumors when they are also mutant for p53? Would these tumors grow even bigger? Also, in the different tumor models that they use, there seems to be a different pattern of p53 activation. With Ras overexpression they observe a pattern very similar to the one they see after irradiation. However, the rest of oncogenic stresses (bam-/-, nanos>CyE, nanos>TkvCA, c587>DPP and c587>Lsd1KD) show a totally different pattern, and in many cases it looks that p53 activation is not restricted to stem cells. In the case of bam-/- they show that there is an expansion of the stem cell population, and that cells that activate p53 also express the germline marker Vasa. Is that also the case for the rest of them? Or otherwise, what would be the explanation for the different pattern of p53 activation? 

4) What is the evidence that the reporter transgene, which contains an enhancer from the known p53 target gene reaper fused to GFP, actually reports all activation of p53? That is, is this reaper enhancer activated in response to p53 activity in all cell types and under all conditions that p53 is “activated”? Without such knowledge, which is admittedly nontrivial to obtain, the main conclusion that “adult Drosophila exposed to genotoxic stress or genome destabilizers selectively activated p53 in GSCs and their immediate progeny” cannot be made. The data in Figure 1–figure supplement 3B' may actually address this point somewhat. These data show that the reporter can be activated in non-GSCs of the ovary when ATR is mutated (both follicle cells and nurse cells it appears, although a better image is needed to make this call). Is this activation p53 dependent? If so, then the restriction of reporter activity to GSCs in response to IR is ATR dependent, which would be somewhat counter intuitive since ATR normally activates p53. What is the activity of the reporter in ATR mutants in the absence of IR? In the absence of additional experiments, a more prudent or expansive interpretation of the current data seems warranted. 

5) There are also problems with the presentation and description of the results. As some examples: – In vertebrates there is strong evidence for a role of p53 as a master regulation of stem cell proliferation and differentiation. Here it appears that they don't see a significant change of stem cell numbers in p53 mutants, but this is never clearly stated. 

– Often an experimental result is given but only cursory information is given to assist the reader in interpreting that result. Some of this is because explanations that belong in the main text are only found in supplementary figure legends. 

– Another example occurs with the introduction of the cuff and aub mutations, where the phenotype of these mutants in ovaries is not described other than to say they are involved in retrotransposon silencing. 

– There are also inconsistencies in some of their results (i.e., biosensor activation outside of the germline) that are not addressed except for the suggestion they result from lack of penetrance or GFP perdurance, etc. How often are these deviations from their model observed? 

DOI: http://dx.doi.org/10.7554/eLife.01530.024

Author response